SARS–CoV‐2 infection and COVID‐19 outcomes in rheumatic diseases: a systematic literature review and meta‐analysis
Objective The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …
COVID-19 vaccination in pregnancy, paediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current …
To date, four vaccines have been authorised for emergency use and under conditional
approval by the European Medicines Agency to prevent COVID-19: Comirnaty, COVID-19 …
approval by the European Medicines Agency to prevent COVID-19: Comirnaty, COVID-19 …
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported …
A Strangfeld, M Schäfer, MA Gianfrancesco… - Annals of the …, 2021 - ard.bmj.com
Objectives To determine factors associated with COVID-19-related death in people with
rheumatic diseases. Methods Physician-reported registry of adults with rheumatic disease …
rheumatic diseases. Methods Physician-reported registry of adults with rheumatic disease …
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the …
Background The risk of severe COVID-19 outcomes in people with immune-mediated
inflammatory diseases and on immune-modifying drugs might not be fully mediated by …
inflammatory diseases and on immune-modifying drugs might not be fully mediated by …
COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
At the beginning of the COVID-19 pandemic, patients with immune-mediated inflammatory
diseases were considered to be at high risk for SARS-CoV-2 infection and the development …
diseases were considered to be at high risk for SARS-CoV-2 infection and the development …
[HTML][HTML] COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. COVID-19 has highly
variable disease severity and a bimodal course characterized by acute respiratory viral …
variable disease severity and a bimodal course characterized by acute respiratory viral …
Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study
Background Real-world evidence on the association between autoimmune inflammatory
rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are …
rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are …
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and …
R Hasseli, U Mueller-Ladner, BF Hoyer, A Krause… - RMD open, 2021 - rmdopen.bmj.com
Introduction Whether patients with inflammatory rheumatic and musculoskeletal diseases
(RMD) are at higher risk to develop severe courses of COVID-19 has not been fully …
(RMD) are at higher risk to develop severe courses of COVID-19 has not been fully …
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease …
Objective To update guidance regarding the management of psoriatic disease during the
COVID-19 pandemic. Study Design The task force (TF) includes 18 physician voting …
COVID-19 pandemic. Study Design The task force (TF) includes 18 physician voting …
Vaccination against COVID-19: expectations and concerns of patients with autoimmune and rheumatic diseases
R Felten, M Dubois, MF Ugarte-Gil… - The Lancet …, 2021 - thelancet.com
Vaccination is an important and effective tool to prevent infections in the general population,
as well as in patients with autoimmune and inflammatory rheumatic diseases. It has been …
as well as in patients with autoimmune and inflammatory rheumatic diseases. It has been …